SARAH BAKER: Open Payments
NPI 1447764758 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 14 payments from 8 companies in 2025. Trend: 2023 $848 · 2024 $0 · 2025 $770
Food & beverage: $484Travel & lodging: $285
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $342 |
| CVRx, Inc. | 1 | $171 |
| E.R. Squibb & Sons, L.L.C. | 1 | $130 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| HEARTFLOW, INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $10 |
Products named: CARDIOMEMS, Barostim Neo System, LEQVIO, WAINUA, FFRct, JARDIANCE, LifeVest.
Industry payments across NE — which companies pay providers there.
